$HAE
HAEMONETICS CORP

2020 Q2 Form 10-Q Financial Statement

#000031314320000065 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2018 Q4
Revenue $195.6M $238.5M $247.4M
YoY Change -17.98% 3.97% 5.69%
Cost Of Revenue $105.5M $122.5M $136.2M
YoY Change -13.87% -16.12% 10.94%
Gross Profit $90.03M $115.9M $111.2M
YoY Change -22.32% 39.24% -0.11%
Gross Profit Margin 46.03% 48.61% 44.95%
Selling, General & Admin $62.30M $73.00M $73.88M
YoY Change -14.65% 6.5% -24.5%
% of Gross Profit 69.2% 62.98% 66.45%
Research & Development $7.750M $7.487M $8.978M
YoY Change 3.51% -20.4% -27.75%
% of Gross Profit 8.61% 6.46% 8.08%
Depreciation & Amortization $20.70M $27.40M $27.90M
YoY Change -24.45% 3.79% 25.11%
% of Gross Profit 22.99% 23.64% 25.1%
Operating Expenses $78.32M $129.2M $82.86M
YoY Change -39.39% 65.76% -24.87%
Operating Profit $11.72M -$13.30M $28.32M
YoY Change -188.07% -351.31% 2695.66%
Interest Expense -$3.700M -$4.400M -$2.900M
YoY Change -15.91% 120.0% 262.5%
% of Operating Profit -31.58% -10.24%
Other Income/Expense, Net -$3.735M -$4.423M -$2.858M
YoY Change -15.56% 123.61% 254.59%
Pretax Income $7.980M -$17.73M $25.46M
YoY Change -145.02% -634.69% 12200.48%
Income Tax -$2.500M -$9.200M $7.200M
% Of Pretax Income -31.33% 28.28%
Net Earnings $10.53M -$8.479M -$8.479M
YoY Change -224.15% 200.78% 29.51%
Net Earnings / Revenue 5.38% -3.56% -3.43%
Basic Earnings Per Share $0.21 -$0.17 $0.36
Diluted Earnings Per Share $0.21 -$0.17 $0.35
COMMON SHARES
Basic Shares Outstanding 50.42M shares 51.01M shares 51.40M shares
Diluted Shares Outstanding 51.25M shares 51.01M shares 52.82M shares

Balance Sheet

Concept 2020 Q2 2019 Q2 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $275.7M $190.2M $154.9M
YoY Change 44.95% -0.99% -38.43%
Cash & Equivalents $275.7M $190.2M $154.9M
Short-Term Investments
Other Short-Term Assets $48.10M $39.80M $24.50M
YoY Change 20.85% 23.6% -24.62%
Inventory $294.5M $222.0M $168.9M
Prepaid Expenses
Receivables $141.1M $163.3M $167.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $759.4M $615.3M $515.9M
YoY Change 23.43% 11.66% -12.52%
LONG-TERM ASSETS
Property, Plant & Equipment $243.0M $276.7M $351.1M
YoY Change -12.21% -12.39% 6.39%
Goodwill $217.3M $211.1M $210.7M
YoY Change 2.92% 0.11% -0.17%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.89M $31.48M $11.48M
YoY Change 128.35% 189.6% -7.64%
Total Long-Term Assets $673.8M $644.3M $711.7M
YoY Change 4.57% -6.64% -1.42%
TOTAL ASSETS
Total Short-Term Assets $759.4M $615.3M $515.9M
Total Long-Term Assets $673.8M $644.3M $711.7M
Total Assets $1.433B $1.260B $1.228B
YoY Change 13.78% 1.49% -6.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.46M $60.79M $62.58M
YoY Change -20.29% -7.04% 50.81%
Accrued Expenses $36.40M $31.40M $51.80M
YoY Change 15.92% -31.44% -17.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $231.4M $117.5M $17.20M
YoY Change 96.83% 589.71% -88.64%
Total Short-Term Liabilities $407.8M $293.7M $211.3M
YoY Change 38.87% 51.38% -34.83%
LONG-TERM LIABILITIES
Long-Term Debt $296.9M $318.1M $326.6M
YoY Change -6.68% -3.84% 175.16%
Other Long-Term Liabilities $106.8M $42.83M $28.17M
YoY Change 149.29% 35.24% -28.87%
Total Long-Term Liabilities $403.7M $361.0M $354.8M
YoY Change 11.83% -0.42% 124.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $407.8M $293.7M $211.3M
Total Long-Term Liabilities $403.7M $361.0M $354.8M
Total Liabilities $811.5M $654.6M $566.1M
YoY Change 23.96% 17.63% 17.32%
SHAREHOLDERS EQUITY
Retained Earnings $89.04M $99.42M $140.6M
YoY Change -10.44% -47.64% -56.56%
Common Stock $563.2M $525.5M $531.6M
YoY Change 7.17% 3.47% 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $608.6M $591.0M $591.0M
YoY Change
Total Liabilities & Shareholders Equity $1.433B $1.260B $1.228B
YoY Change 13.78% 1.49% -6.41%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2018 Q4
OPERATING ACTIVITIES
Net Income $10.53M -$8.479M -$8.479M
YoY Change -224.15% 200.78% 29.51%
Depreciation, Depletion And Amortization $20.70M $27.40M $27.90M
YoY Change -24.45% 3.79% 25.11%
Cash From Operating Activities $11.81M $2.628M $58.10M
YoY Change 349.47% -88.63% -11.16%
INVESTING ACTIVITIES
Capital Expenditures $7.696M $8.249M -$29.20M
YoY Change -6.7% -70.02% 9.77%
Acquisitions $16.61M $0.00
YoY Change
Other Investing Activities -$16.20M $10.10M $1.600M
YoY Change -260.4% 3266.67% 433.33%
Cash From Investing Activities -$23.90M $1.861M -$27.60M
YoY Change -1384.04% -106.83% 4.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $75.00M
YoY Change -6.25%
Debt Paid & Issued, Net $4.375M $4.375M
YoY Change 0.0% -98.28%
Cash From Financing Activities $149.0M $16.09M -76.20M
YoY Change 825.74% -13.79% -1018.07%
NET CHANGE
Cash From Operating Activities $11.81M $2.628M 58.10M
Cash From Investing Activities -$23.90M $1.861M -27.60M
Cash From Financing Activities $149.0M $16.09M -76.20M
Net Change In Cash $138.4M $20.88M -45.70M
YoY Change 562.81% 43.81% -196.41%
FREE CASH FLOW
Cash From Operating Activities $11.81M $2.628M $58.10M
Capital Expenditures $7.696M $8.249M -$29.20M
Free Cash Flow $4.116M -$5.621M $87.30M
YoY Change -173.23% 27.98% -5.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000313143
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-03
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4108000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3937000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
279154000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
263479000 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50607751 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51019918 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50607751 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51019918 shares
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-06-27
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-14041
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2882273
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
125 Summer Street
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
CY2020Q2 dei City Area Code
CityAreaCode
781
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
848-7100
CY2020Q2 dei Security12b Title
Security12bTitle
Common stock, $.01 par value per share
CY2020Q2 dei Trading Symbol
TradingSymbol
HAE
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50699118 shares
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195577000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238451000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
105547000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
122545000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
90030000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
115906000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7750000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7487000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69537000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73000000 USD
CY2020Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1028000 USD
CY2019Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
48721000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
78315000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
129208000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11715000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13302000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3735000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4423000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7980000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17725000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2547000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9246000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50418000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51010000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51247000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51010000 shares
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11956000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12097000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
275725000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
141094000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165207000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
294510000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
48081000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30845000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
759410000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
603639000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242969000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253399000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
137520000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
133106000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
217298000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
210652000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4088000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3930000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71888000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62384000 USD
CY2020Q2 us-gaap Assets
Assets
1433173000 USD
CY2020Q1 us-gaap Assets
Assets
1267110000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
231364000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
76980000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
48459000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
50730000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36409000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49471000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
91595000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97641000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
407827000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
274822000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
296893000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
305513000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13116000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10562000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
106768000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
89104000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
503000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
562729000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553229000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
89039000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
78512000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43706000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
608569000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1433173000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1267110000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2144000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1193000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6167000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1429000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
608569000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
667868000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1830000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3635000 USD
CY2018Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2018Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4730000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2018Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3618000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
590966000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20724000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27437000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1028000 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
48721000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6167000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4730000 USD
CY2020Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-501000 USD
CY2019Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-5309000 USD
CY2020Q2 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1193000 USD
CY2019Q2 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1378000 USD
CY2020Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
66000 USD
CY2019Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
50000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25067000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-22518000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24557000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37414000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
3544000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
3228000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-865000 USD
CY2019Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8208000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25223000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36812000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11812000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2628000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7696000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8249000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16606000 USD
CY2019Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020Q2 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2019Q2 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9808000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
406000 USD
CY2019Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
302000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23896000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1861000 USD
CY2020Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
150000000 USD
CY2019Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
90000000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4375000 USD
CY2019Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4375000 USD
CY2020Q2 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
CY2019Q2 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
75000000 USD
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
2144000 USD
CY2019Q2 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
1830000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1193000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3635000 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000 USD
CY2019Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
148951000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16090000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1547000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
304000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
138414000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20883000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169351000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
275725000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190234000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
2780000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
3535000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2063000 USD
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3078000 USD
CY2020Q2 hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
2364000 USD
CY2019Q2 hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
2973000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
2648000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
1065000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
1174000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2539000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
1065000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
969000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2500000 USD
CY2020Q2 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
2100000 USD
CY2020Q2 hae Restructuring Related Costs
RestructuringRelatedCosts
2900000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
1065000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
969000 USD
CY2020Q2 hae Restructuring Related Costs
RestructuringRelatedCosts
2935000 USD
CY2019Q2 hae Restructuring Related Costs
RestructuringRelatedCosts
1058000 USD
CY2020Q2 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
4000000 USD
CY2019Q2 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
2027000 USD
CY2020Q2 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
200000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2500000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.319
CY2020Q2 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
4000000.0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9200000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.522
CY2019Q2 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
4900000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50418000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51010000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50418000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51010000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
829000 shares
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51247000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51010000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21900000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.62
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6100000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5000000.0 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21500000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20800000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8900000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76224000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76867000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11351000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11021000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
206935000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
182388000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
294510000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3824000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3937000 USD
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
259000 USD
CY2019Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
299000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
119000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3446000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3624000 USD
CY2020Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2020Q2 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
193600000 USD
CY2019Q2 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
235946000 USD
CY2020Q2 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-3105000 USD
CY2019Q2 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-2361000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195577000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238451000 USD
CY2020Q2 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
711000 USD
CY2019Q2 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
2769000 USD
CY2020Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
964000 USD
CY2019Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
51166000 USD
CY2020Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
8263000 USD
CY2019Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5974000 USD
CY2020Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
1542000 USD
CY2019Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
5528000 USD
CY2020Q2 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
4000000 USD
CY2019Q2 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
2027000 USD
CY2020Q2 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
753000 USD
CY2019Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-33000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1290000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11715000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13302000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195577000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238451000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195577000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238451000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
287000 USD
CY2020Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1142000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1429000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43706000 USD

Files In Submission

Name View Source Status
0000313143-20-000065-index-headers.html Edgar Link pending
0000313143-20-000065-index.html Edgar Link pending
0000313143-20-000065.txt Edgar Link pending
0000313143-20-000065-xbrl.zip Edgar Link pending
ex101toform10-qq1offis.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hae-20200627.htm Edgar Link pending
hae-20200627.xsd Edgar Link pending
hae-20200627_cal.xml Edgar Link unprocessable
hae-20200627_def.xml Edgar Link unprocessable
hae-20200627_htm.xml Edgar Link completed
hae-20200627_lab.xml Edgar Link unprocessable
hae-20200627_pre.xml Edgar Link unprocessable
haeq1jun2021ex311.htm Edgar Link pending
haeq1jun2021ex312.htm Edgar Link pending
haeq1jun2021ex321.htm Edgar Link pending
haeq1jun2021ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending